| Malignant disease | |||||
|---|---|---|---|---|---|
| Malignant disease / Antibody responsive malignancy | |||||
| atezolizumab [Specialist drug] | On Formulary |
NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA1071 NICE TA638 NICE TA639 NICE TA666 |
|||
| avelumab [Specialist drug] | Prior approval required (blueteq) |
NICE TA517 NICE TA691 NICE TA645 NICE TA788 |
|||
| Solution for infusion | |||||
| Bavencio (Merck Serono Ltd) | Prior approval required (blueteq) | ||||
| bevacizumab [Specialist drug] | Restricted |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA946 NICE TA1022 |
|||
| Solution for infusion | |||||
| Avastin (Roche Products Ltd) | Restricted | ||||
| blinatumomab [Specialist drug] | On Formulary |
NICE TA450 NICE TA589 NICE TA1049 |
|||
| brentuximab vedotin [Specialist drug] | Prior approval required (blueteq) |
NICE TA478 NICE TA641 NICE TA524 NICE TA1059 NICE TA577 |
|||
| cetuximab [Specialist drug] | On Formulary |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
|||
| Solution for infusion | |||||
| Erbitux (Merck Serono Ltd) | On Formulary | ||||
| daratumumab | Prior approval required (blueteq) |
NICE TA763 NICE TA783 NICE TA897 NICE TA917 NICE TA959 |
|||
| dostarlimab [Specialist drug] | Prior approval required (blueteq) |
NICE TA779 NICE TA1064 |
|||
| durvalumab [Specialist drug] | On Formulary |
NICE TA798 NICE TA1030 NICE TA1041 NICE TA1099 NICE TA944 NICE TA1090 |
|||
| gemtuzumab ozogamicin [Specialist drug] | Prior approval required (blueteq) |
NICE TA545 |
|||
| Powder for solution for infusion | |||||
| Mylotarg (Pfizer Ltd) | Prior approval required (blueteq) | ||||
| glofitamab [Specialist drug] | Prior approval required (blueteq) |
NICE TA927 |
|||
| inotuzumab ozogamicin [Specialist drug] | Restricted |
NICE TA541 |
|||
| Powder for solution for infusion | |||||
| Besponsa (Pfizer Ltd) | Restricted | ||||
| ipilimumab [Specialist drug] | Prior approval required (blueteq) |
NICE TA268 NICE TA319 NICE TA400 NICE TA716 NICE TA1065 NICE TA724 NICE TA780 NICE TA818 |
|||
| Solution for infusion | |||||
| Yervoy (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| isatuximab [Specialist drug] | Prior approval required (blueteq) |
NICE TA658 NICE TA1098 |
|||
| nivolumab [Specialist drug] | Prior approval required (blueteq) |
NICE TA384 NICE TA400 NICE TA684 NICE TA417 NICE TA780 NICE TA964 NICE TA462 NICE TA655 NICE TA713 NICE TA724 NICE TA876 NICE TA530 NICE TA817 NICE TA707 NICE TA746 NICE TA857 NICE TA865 NICE TA716 NICE TA1065 NICE TA736 NICE TA818 |
|||
| Solution for infusion | |||||
| Opdivo (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| obinutuzumab [Specialist drug] | On Formulary |
NICE TA343 NICE TA513 NICE TA629 |
|||
| pembrolizumab [Specialist drug] | Prior approval required (blueteq) |
NICE TA357 NICE TA366 NICE TA766 NICE TA837 NICE TA428 NICE TA531 NICE TA683 NICE TA770 NICE TA1017 NICE TA1037 NICE TA692 NICE TA1097 NICE TA772 NICE TA540 NICE TA967 NICE TA650 NICE TA830 NICE TA858 NICE TA661 NICE TA709 NICE TA914 NICE TA983 NICE TA737 NICE TA997 NICE TA801 NICE TA851 NICE TA939 NICE TA904 NICE TA1092 |
|||
| Solution for infusion | |||||
| Keytruda (Merck Sharp & Dohme (UK) Ltd) | Restricted | ||||
| pertuzumab [Specialist drug] | Restricted |
NICE TA424 NICE TA509 NICE TA569 |
|||
| Solution for infusion | |||||
| Perjeta (Roche Products Ltd) | Restricted | ||||
| pertuzumab with trastuzumab [Specialist drug] | Restricted | ||||
| Solution for injection | |||||
| Phesgo (Roche Products Ltd) | Restricted | ||||
| polatuzumab vedotin [Specialist drug] | Restricted |
NICE TA649 NICE TA874 |
|||
| Powder for solution for infusion | |||||
| Polivy (Roche Products Ltd) | Restricted | ||||
| rituximab | Restricted |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
| teclistamab [Specialist drug] | Prior approval required (blueteq) |
NICE TA1015 |
|||
| trastuzumab [Specialist drug] | Restricted |
NICE TA34 NICE TA257 NICE TA509 NICE TA208 |
|||
| trastuzumab deruxtecan [Specialist drug] | Prior approval required (blueteq) |
NICE TA704 NICE TA862 NICE TA992 |
|||
| Malignant disease / Immunotherapy responsive malignancy | |||||
| Bacillus Calmette-Guérin [Specialist drug] | Restricted | ||||
| Powder for reconstitution for instillation | |||||
| OncoTICE (Merck Sharp & Dohme (UK) Ltd) | Restricted | ||||
| lenalidomide [Specialist drug] | Restricted |
NICE TA322 NICE TA171 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
| thalidomide [Specialist drug] | Restricted |
NICE TA228 |
|||
| Malignant disease / Targeted therapy responsive malignancy | |||||
| abemaciclib [Specialist drug] | Restricted |
NICE TA563 NICE TA725 NICE TA810 |
|||
| acalabrutinib [Specialist drug] | Restricted |
NICE TA689 NICE TA689 |
|||
| afatinib [Specialist drug] | Restricted |
NICE TA310 |
|||
| alectinib [Specialist drug] | Restricted |
NICE TA536 NICE TA1014 |
|||
| axitinib [Specialist drug] | Restricted |
NICE TA333 NICE TA645 NICE TA650 |
|||
| bortezomib [Specialist drug] | Restricted |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
|||
| Powder for solution for injection | |||||
| Velcade (Janssen-Cilag Ltd) | Restricted | ||||
| bosutinib [Specialist drug] | Restricted |
NICE TA401 |
|||
| cabozantinib [Specialist drug] | Prior approval required (blueteq) |
NICE TA463 NICE TA542 NICE TA964 NICE TA516 NICE TA928 NICE TA849 |
|||
| crizotinib [Specialist drug] | Restricted |
NICE TA406 NICE TA422 NICE TA1021 |
|||
| dasatinib [Specialist drug] | Restricted |
NICE TA426 NICE TA425 |
|||
| entrectinib [Specialist drug] | Restricted |
NICE TA643 NICE TA644 |
|||
| erlotinib [Specialist drug] | Restricted |
NICE TA227 NICE TA258 NICE TA374 NICE TA374 |
|||
| everolimus | Restricted |
NICE TA421 NICE TA432 NICE TA449 |
|||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| gefitinib [Specialist drug] | Restricted |
NICE TA192 NICE TA374 |
|||
| gilteritinib [Specialist drug] | Prior approval required (blueteq) |
NICE TA642 |
|||
| ibrutinib [Specialist drug] | Restricted |
NICE TA429 NICE TA891 NICE TA502 NICE TA795 |
|||
| idelalisib [Specialist drug] | Restricted |
NICE TA359 NICE TA604 |
|||
| imatinib [Specialist drug] | Restricted |
NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425 |
|||
| ixazomib [Specialist drug] | Restricted |
NICE TA870 |
|||
| midostaurin [Specialist drug] | Restricted |
NICE TA523 NICE TA728 |
|||
| nilotinib [Specialist drug] | Restricted |
NICE TA426 NICE TA425 |
|||
| nintedanib | Prior approval required (blueteq) |
NICE TA347 NICE TA379 NICE TA864 NICE TA747 |
|||
| niraparib [Specialist drug] | Prior approval required (blueteq) |
NICE TA673 NICE TA784 |
|||
| olaparib [Specialist drug] | Prior approval required (blueteq) |
NICE TA908 NICE TA946 NICE TA962 NICE TA886 NICE TA1040 NICE TA887 NICE TA951 |
|||
| osimertinib [Specialist drug] | Prior approval required (blueteq) |
NICE TA653 NICE TA654 NICE TA1043 NICE TA1060 |
|||
| pazopanib [Specialist drug] | Restricted |
NICE TA215 |
|||
| rucaparib [Specialist drug] | On Formulary |
NICE TA1007 NICE TA1055 |
|||
| ruxolitinib | Restricted |
NICE TA386 NICE TA921 NICE TA1054 |
|||
| sorafenib [Specialist drug] | Restricted |
NICE TA178 NICE TA474 NICE TA535 |
|||
| sunitinib [Specialist drug] | Prior approval required (blueteq) |
NICE TA169 NICE TA179 NICE TA178 NICE TA449 |
|||
| vemurafenib [Specialist drug] | Restricted |
NICE TA269 |
|||
| venetoclax [Specialist drug] | Restricted |
NICE TA561 NICE TA663 NICE TA796 NICE TA765 NICE TA787 |
|||
| zanubrutinib [Specialist drug] | Restricted |
NICE TA833 NICE TA931 NICE TA1001 NICE TA1081 |
|||
| Malignant disease / Cytotoxic responsive malignancy | |||||
| azacitidine [Specialist drug] | Restricted |
NICE TA218 NICE TA399 NICE TA827 |
|||
| Powder for suspension for injection | |||||
| Azacitidine (Non-proprietary) | Restricted | ||||
| bendamustine hydrochloride [Specialist drug] | Prior approval required (blueteq) |
NICE TA216 NICE TA472 |
|||
| bexarotene [Specialist drug] | On Formulary | ||||
| bleomycin [Specialist drug] | On Formulary | ||||
| busulfan [Specialist drug] | On Formulary | ||||
| capecitabine [Specialist drug] | On Formulary |
NICE TA263 NICE TA212 NICE TA191 NICE TA61 NICE TA100 |
|||
| carboplatin [Specialist drug] | On Formulary |
NICE TA284 NICE TA285 |
|||
| Solution for infusion | |||||
| Carboplatin (Non-proprietary) | On Formulary | ||||
| chlorambucil [Specialist drug] | On Formulary |
NICE TA343 NICE TA344 |
|||
| cisplatin [Specialist drug] | On Formulary | ||||
| Solution for infusion | |||||
| Cisplatin (Non-proprietary) | On Formulary | ||||
| cladribine | On Formulary |
NICE TA616 NICE TA1053 |
|||
| clofarabine [Specialist drug] | Non Formulary | ||||
| Solution for infusion | |||||
| Clofarabine (Non-proprietary) | Restricted | ||||
| cyclophosphamide | On Formulary | ||||
| Powder for solution for injection | |||||
| Cyclophosphamide (Non-proprietary) | On Formulary | ||||
| cytarabine [Specialist drug] | On Formulary | ||||
| Solution for injection | |||||
| Cytarabine (Non-proprietary) | On Formulary | ||||
| dacarbazine [Specialist drug] | On Formulary | ||||
| daunorubicin [Specialist drug] | On Formulary | ||||
| docetaxel [Specialist drug] | Restricted |
NICE TA101 NICE TA509 |
|||
| doxorubicin hydrochloride [Specialist drug] | On Formulary |
NICE TA389 NICE TA465 |
|||
| epirubicin hydrochloride [Specialist drug] | On Formulary | ||||
| eribulin [Specialist drug] | Restricted |
NICE TA423 NICE TA515 |
|||
| etoposide [Specialist drug] | Restricted | ||||
| fludarabine phosphate [Specialist drug] | On Formulary |
NICE TA119 NICE TA29 |
|||
| fluorouracil | Restricted | ||||
| gemcitabine [Specialist drug] | On Formulary |
NICE TA25 NICE TA116 NICE TA285 NICE TA389 NICE TA476 |
|||
| hydroxycarbamide | Restricted | ||||
| idarubicin hydrochloride [Specialist drug] | On Formulary | ||||
| ifosfamide [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Ifosfamide (Non-proprietary) | On Formulary | ||||
| irinotecan hydrochloride [Specialist drug] | Restricted |
NICE TA440 |
|||
| Solution for infusion | |||||
| Irinotecan hydrochloride (Non-proprietary) | Restricted | ||||
| Campto (Pfizer Ltd) | Restricted | ||||
| melphalan [Specialist drug] | On Formulary | ||||
| mercaptopurine | Restricted | ||||
| methotrexate | On Formulary | ||||
| Solution for infusion | |||||
| Methotrexate (Non-proprietary) | On Formulary | ||||
| mitomycin [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Mitomycin (Non-proprietary) | On Formulary | ||||
| mitoxantrone [Specialist drug] | On Formulary | ||||
| oxaliplatin [Specialist drug] | On Formulary |
NICE TA100 NICE TA93 |
|||
| paclitaxel [Specialist drug] | Restricted |
NICE TA55 NICE TA284 NICE TA389 NICE TA476 |
|||
| Solution for infusion | |||||
| Paclitaxel (Non-proprietary) | Restricted | ||||
| pemetrexed [Specialist drug] | On Formulary |
NICE TA124 NICE TA181 NICE TA402 NICE TA190 NICE TA135 |
|||
| pentostatin [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Nipent (Pfizer Ltd) | On Formulary | ||||
| pixantrone [Specialist drug] | Restricted |
NICE TA306 |
|||
| procarbazine [Specialist drug] | On Formulary | ||||
| streptozocin [Specialist drug] | Restricted | ||||
| Powder for solution for infusion | |||||
| Zanosar (Esteve Pharmaceuticals Ltd) | Restricted | ||||
| temozolomide [Specialist drug] | Restricted |
NICE TA23 NICE TA121 |
|||
| thiotepa [Specialist drug] | Restricted | ||||
| Powder for solution for infusion | |||||
| Thiotepa (Non-proprietary) | Restricted | ||||
| tioguanine [Specialist drug] | On Formulary | ||||
| topotecan [Specialist drug] | Restricted |
NICE TA183 NICE TA184 NICE TA389 |
|||
| Solution for infusion | |||||
| Topotecan (Non-proprietary) | Restricted | ||||
| treosulfan [Specialist drug] | Restricted |
NICE TA640 |
|||
| Powder for solution for injection | |||||
| Treosulfan (Non-proprietary) | Restricted | ||||
| tretinoin [Specialist drug] | Restricted | ||||
| trifluridine with tipiracil [Specialist drug] | Restricted |
NICE TA405 NICE TA1008 NICE TA852 |
|||
| vinblastine sulfate [Specialist drug] | On Formulary | ||||
| Solution for injection | |||||
| Vinblastine sulfate (Non-proprietary) | On Formulary | ||||
| vincristine sulfate [Specialist drug] | On Formulary | ||||
| vindesine sulfate [Specialist drug] | On Formulary | ||||
| Powder for solution for injection | |||||
| Eldisine (Genus Pharmaceuticals Ltd) | On Formulary | ||||
| vinorelbine [Specialist drug] | On Formulary | ||||
| Malignant disease / Cytotoxic drug-induced side effects | |||||
| dexrazoxane | Restricted | ||||
| Powder and solvent for solution for infusion | |||||
| Savene (CNX Therapeutics Ltd) | Restricted | ||||
| folinic acid | On Formulary |
NICE TA212 |
|||
| Solution for injection | |||||
| Folinic acid (Non-proprietary) | On Formulary | ||||
| mesna | On Formulary | ||||
| Solution for injection | |||||
| Mesna (Non-proprietary) | On Formulary | ||||
| Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
| allopurinol | On Formulary | ||||
| febuxostat | Restricted |
NICE TA164 |
|||
| rasburicase | On Formulary | ||||
| Powder and solvent for solution for infusion | |||||
| Fasturtec (Sanofi) | On Formulary | ||||
| Malignant disease / Hormone responsive malignancy | |||||
| abiraterone acetate | Restricted |
NICE TA259 NICE TA387 NICE TA1110 |
|||
| apalutamide | Restricted |
NICE TA740 NICE TA741 |
|||
| bicalutamide | On Formulary | ||||
| cyproterone acetate | On Formulary | ||||
| darolutamide | Restricted |
NICE TA660 NICE TA903 NICE TA1109 |
|||
| degarelix | Restricted |
NICE TA404 |
|||
| diethylstilbestrol | On Formulary | ||||
| enzalutamide | Restricted |
NICE TA316 NICE TA377 NICE TA580 NICE TA712 |
|||
| ethinylestradiol | Restricted | ||||
| goserelin | On Formulary | ||||
| lanreotide | On Formulary | ||||
| leuprorelin acetate | On Formulary | ||||
| medroxyprogesterone acetate | On Formulary | ||||
| megestrol acetate | On Formulary | ||||
| norethisterone | On Formulary | ||||
| octreotide | On Formulary | ||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | On Formulary | ||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||
| triptorelin | On Formulary | ||||
| Malignant disease / Hormone responsive breast cancer | |||||
| anastrozole | Restricted | ||||
| elacestrant | On Formulary |
NICE TA1036 |
|||
| exemestane | Restricted | ||||
| fulvestrant | Restricted |
NICE TA503 |
|||
| letrozole | Restricted | ||||
| tamoxifen | On Formulary | ||||
| Oral solution | |||||
| Tamoxifen (Non-proprietary) | Restricted | ||||
| Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
| calcitonin (salmon) | Restricted | ||||
| Solution for injection | |||||
| Calcitonin (salmon) (Non-proprietary) | Restricted | ||||
| denosumab | Restricted |
NICE TA204 NICE TA265 |
|||
| ibandronic acid | Restricted |
NICE TA464 |
|||
| Solution for injection | |||||
| Ibandronic acid (Non-proprietary) | Restricted | ||||
| Solution for infusion | |||||
| Ibandronic acid (Non-proprietary) | Restricted | ||||
| zoledronic acid | On Formulary |
NICE TA464 |
|||
| Infusion | |||||
| Zoledronic acid (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Zoledronic acid (Non-proprietary) | On Formulary | ||||